Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Faxon

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Journal of the American College of Cardiology|September 5, 2015
Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary StentingArun K Thukkani, Kush Agrawal, Lillian Prince, et al.
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiologyDavid P Faxon, Valentin Fuster, Peter Libby, et al.
Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.
Circulation|January 13, 2006
Payment for quality: guiding principles and recommendations: principles and recommendations from the American Heart Association's Reimbursement, Coverage, and Access Policy Development WorkgroupVincent Bufalino, Eric D Peterson, Gregory L Burke, et al.
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart AssociationDavid P Faxon, Mark A Creager, Sidney C Smith, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 21, 2003
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)Melvin D Cheitlin, William F Armstrong, Gerard P Aurigemma, et al.
Journal of the American Heart Association|November 5, 2017
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionMatthias Bossard, Christopher B Granger, Jean-Francois Tanguay, et al.
The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Journal of the American College of Cardiology|September 5, 2015
Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary StentingArun K Thukkani, Kush Agrawal, Lillian Prince, et al.
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiologyDavid P Faxon, Valentin Fuster, Peter Libby, et al.
Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.
Circulation|January 13, 2006
Payment for quality: guiding principles and recommendations: principles and recommendations from the American Heart Association's Reimbursement, Coverage, and Access Policy Development WorkgroupVincent Bufalino, Eric D Peterson, Gregory L Burke, et al.
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart AssociationDavid P Faxon, Mark A Creager, Sidney C Smith, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 21, 2003
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)Melvin D Cheitlin, William F Armstrong, Gerard P Aurigemma, et al.
Journal of the American Heart Association|November 5, 2017
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionMatthias Bossard, Christopher B Granger, Jean-Francois Tanguay, et al.
The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Pageof 18